Zantac Lawsuits

Call for a FREE Consultation: (888) 592-8455

On April 1, 2020, the FDA issued a market withdrawal of all Zantac (ranitidine) products. The FDA determined that Zantac contained dangerous levels of N-Nitrosodimethylamine (NDMA). The result was consumer exposure to unacceptable levels of NDMA. The Environmental Protection Agency (EPA), the World Health Organization (WHO), and the FDA all classify NDMA as a carcinogen, a substance capable of causing cancer. Prior to the FDA recall, many manufacturers of Zantac had already issued voluntary recalls of their own.

NDMA is in Zantac

In June of 2019, Valisure, a pharmacy that chemically validates medications for consistency and quality issues, discovered extremely high levels of NDMA in ranitidine and subsequently filed a petition requesting that the FDA recall all products containing ranitidine, the key ingredient in Zantac.

Valisure’s findings were consistent with various university and independent studies that had already found NDMA in Zantac. The evidence presented in the Valisure and other studies show that the NDMA in Zantac is a likely human carcinogen.

Another petition was filed with the FDA, noting that ranitidine is time- and temperature-sensitive and also tends to develop into NDMA when exposed to heat. Exposure to high temperatures is a common occurrence during transportation and storage and is of specific concern to ranitidine as there are currently no requirements for the drug to be shipped in temperature-controlled conditions or stored under refrigeration.

Zantac’s Link to Cancer

Since the FDA approved Zantac in the 1980s, numerous studies have shown a link between ranitidine and cancer.

NDMA belongs to a family of chemicals known as N-nitrosamines. According to the EPA, N-nitrosamines are part of “a family of potent carcinogens.” NDMA was originally used as a component in rocket fuel, but in the early 1970s it was discovered that NDMA is a potent carcinogen and as a result, NDMA is no longer intentionally manufactured or used in anything outside of scientific testing. Animal testing of NDMA has found that it causes very high rates of certain types of cancer. It is now widely accepted that it causes cancer.

Contact Meyer Wilson About a Potential Zantac Lawsuit

The public relies on pharmaceutical companies and others to ensure medications such as Zantac are safe. The attorneys at Meyer Wilson hold drug manufacturers accountable when those manufacturers fail to prioritize the safety of consumers. More recent studies have shown Zantac to be linked to the following types of cancer:

  • Bladder Cancer
  • Breast Cancer
  • Colorectal/Intestinal Cancer
  • Esophageal Cancer
  • Gastric/Stomach Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Lung Cancer (non-smoker)

If you or a member of your family took Zantac (ranitidine) and developed one of the above cancers, contact us today for a risk-free, no-cost case evaluation. You may be entitled to significant compensation. Pharmaceutical litigation is a complex process and the attorneys at Meyer Wilson have years of experience holding big corporations accountable for concealing the dangers of consumer products.

Ready to Speak with an Attorney?

Schedule a Free Consultation With Our Firm By Calling (888) 592-8455
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.